Patients are playing an increasingly important role in creating relevant healthcare data about themselves using mobile devices and applications. It is important this data can move with them securely throughout a healthcare ecosystem. The increased use of medical devices and mobile applications opens the dialogue around open source and non-proprietary standards with complementing policies.
This SlideShare covers the utilization of telehealth products and services by healthcare organizations, as well as the reasons driving their adoption. This session will focus on reasons to adopt telehealth as a service line, the types of technologies widely deployed, and the financial implications associated with offering care in a virtual setting.
Learning objectives:
• Review the current landscape of telehealth
• Assess the approach to using technology to provide care in a virtual setting
• Recognize the financial impacts and reasoning associated with telehealth services
Patient Engagement Power Team Comments – Leslie Kelly Hall, ChairBrian Ahier
The Consumer/Patient Engagement Power Team will assess Standards and Certification Criteria NPRM and provide recommendations for strengthening consumer/patient engagement components. The Power Team will prioritize recommendations to enable patients to participate as partners in their care.
Innovations and Trends in Health Care: The Advent and Use of Personal Health ...Mark Silverberg
My semester-long research project in HSCI 2109 is about the advent and use of a very interesting innovation in health care: the Personal Health Record). This presentation is a mid-semester check-in with my fellow students to educate them about some key definitions, stakeholders, barriers, and recommendations I have gathered around system development and implementation of PHRs.
This is a topic I am very interested and invested in so I would be happy to discuss it with anyone who is interested!
This SlideShare covers the utilization of telehealth products and services by healthcare organizations, as well as the reasons driving their adoption. This session will focus on reasons to adopt telehealth as a service line, the types of technologies widely deployed, and the financial implications associated with offering care in a virtual setting.
Learning objectives:
• Review the current landscape of telehealth
• Assess the approach to using technology to provide care in a virtual setting
• Recognize the financial impacts and reasoning associated with telehealth services
Patient Engagement Power Team Comments – Leslie Kelly Hall, ChairBrian Ahier
The Consumer/Patient Engagement Power Team will assess Standards and Certification Criteria NPRM and provide recommendations for strengthening consumer/patient engagement components. The Power Team will prioritize recommendations to enable patients to participate as partners in their care.
Innovations and Trends in Health Care: The Advent and Use of Personal Health ...Mark Silverberg
My semester-long research project in HSCI 2109 is about the advent and use of a very interesting innovation in health care: the Personal Health Record). This presentation is a mid-semester check-in with my fellow students to educate them about some key definitions, stakeholders, barriers, and recommendations I have gathered around system development and implementation of PHRs.
This is a topic I am very interested and invested in so I would be happy to discuss it with anyone who is interested!
Ailsa Claire: Commissioning Intelligence ProgrammeThe King's Fund
Ailsa Claire, Director of Commissioning Development, NHS Yorkshire and Humber, talks on the Commissioning Intelligence programme: What have we learned so far?
Karen Bell, MD, MMS
Director, Center for Sustainable Health and Care
JBS International, Inc.
Former Chair
Certification Commission for Health Information Technology
To make remote monitoring devices interoperable, we must examine a variety of use cases and the current evidence of their effectiveness. The presentation is from the January 2020 IHE Connectathon in Cleveland, Oho.
Network physicians, hospitals, and other care continuum providers work collaboratively in active clinical process improvement programs across service lines and specialties to define, establish, implement, monitor, evaluate and periodically update the processes of:
- Evidence-based medicine
- Beneficiary engagement
- Care coordination
- Conservation of healthcare resources
- Clinical data reporting
Qualitative Research in Results-Based Financing: The Promise and The RealityRBFHealth
A presentation by Kerina Kielmann and Fabian Cataldo, delivered at the RBF Health Seminar, Qualitative Research in RBF: The Promise and The Reality on February 18, 2015.
WHO Implementation Research Program on Factors Explaining Success and Failure...RBFHealth
A presentation by Maryam Bigdeli, delivered during "Transforming Health Systems Through Results-Based Financing," an event held during the Third Global Symposium on Health Systems Research in Cape Town on September 30, 2014. This event was hosted by the Health Results Innovation Trust Fund at The World Bank, in partnership with the PBF Community of Practice in Africa.
Patient Engagement is more that an patient portal
Connected Health tools are available to enhance engagement
Personalization is needed to engage
How patient engagement technologies fit with population health
Helping those lacking health and digital literacy and access
The future is bright for Personal Connected Health
Ailsa Claire: Commissioning Intelligence ProgrammeThe King's Fund
Ailsa Claire, Director of Commissioning Development, NHS Yorkshire and Humber, talks on the Commissioning Intelligence programme: What have we learned so far?
Karen Bell, MD, MMS
Director, Center for Sustainable Health and Care
JBS International, Inc.
Former Chair
Certification Commission for Health Information Technology
To make remote monitoring devices interoperable, we must examine a variety of use cases and the current evidence of their effectiveness. The presentation is from the January 2020 IHE Connectathon in Cleveland, Oho.
Network physicians, hospitals, and other care continuum providers work collaboratively in active clinical process improvement programs across service lines and specialties to define, establish, implement, monitor, evaluate and periodically update the processes of:
- Evidence-based medicine
- Beneficiary engagement
- Care coordination
- Conservation of healthcare resources
- Clinical data reporting
Qualitative Research in Results-Based Financing: The Promise and The RealityRBFHealth
A presentation by Kerina Kielmann and Fabian Cataldo, delivered at the RBF Health Seminar, Qualitative Research in RBF: The Promise and The Reality on February 18, 2015.
WHO Implementation Research Program on Factors Explaining Success and Failure...RBFHealth
A presentation by Maryam Bigdeli, delivered during "Transforming Health Systems Through Results-Based Financing," an event held during the Third Global Symposium on Health Systems Research in Cape Town on September 30, 2014. This event was hosted by the Health Results Innovation Trust Fund at The World Bank, in partnership with the PBF Community of Practice in Africa.
Patient Engagement is more that an patient portal
Connected Health tools are available to enhance engagement
Personalization is needed to engage
How patient engagement technologies fit with population health
Helping those lacking health and digital literacy and access
The future is bright for Personal Connected Health
Arduino Day 2016 - Arduino, pasado y presenteAlberto Serna
Brief talk about the origin of Arduino and the whole open source community that has grown around it and about some real projects implemented using Arduino as prototyping platform.
Scenario:
Midwest Regional Health is one of Wisconsin's largest and most sophisticated hospitals, is Implementing a new EHR system that will better their services to their internal and external customers. They are asking ITMC (I-Tech Medical Consortium) to help them navigate through this long term project, thereby improving their commitment to their surrounding community.
2016 IBM Interconnect - medical devices transformationElizabeth Koumpan
Emerging technologies such as Internet of Things, 3D Printing are driving the creation of new business models and forcing the Industry for transformation. The product centric model where the Industry main objective was to develop the device, is moving to software and services model, with the focus on Big Data & Analytics, Integration and Cloud.
The maturation of technologies such as social, mobile, analytics, cloud, 3D printing, bio- and nanotechnology are rapidly shifting the competitive landscape. These emerging technologies create an environment that is connected and open, simple and intelligent, fast and scalable. Organizations must embrace disruptive technologies to drive innovation
What you need to know about Meaningful Use 2 & interoperabilityCompliancy Group
Does this describe you?
·You are constantly challenged to stay abreast of the latest information on EHR integration and HIE interoperability, Meaningful Use stages, the Direct Project, clinician and patient portals, just to name a few.
·You walk a fine line between adopting health information technology for the good it can bring patient outcomes…….and for the good incentive dollars it can mean to your organization.
·You play a key role in ensuring your organization can attest for meaningful use.
Join Andy Nieto, Health IT Strategist at DataMotion where he’ll explain the key role that interoperability plays in Meaningful Use Stage 2 attestation including:
- What does interoperability really mean
- Why you can’t ignore interoperability
- How to achieve interoperability and make it meaningful
- What you need in order to attest
Health device makers, to date, have primarily targeted consumers who are either fitness focused or chronically ill. But between these two extremes sits a large, fragmented and often overlooked population who seek better information to effectively manage their health. Our research suggests that successful solution providers will approach this market opportunity as an ecosystem of partners – with an integrated solution that extends beyond the device itself. By plugging the information gap for these consumers, solution providers can help fuel healthcare innovation.
Health device makers, to date, have primarily targeted consumers who are either fitness focused or chronically ill. But between these two extremes sits a large, fragmented and often overlooked population who seek better information to effectively manage their health. Our research suggests that successful solution providers will approach this market opportunity as an ecosystem of partners – with an integrated solution that extends beyond the device itself. By plugging the information gap for these consumers, solution providers can help fuel healthcare innovation.
Health Data Exchange:. Still a Pipe Dream? A Presentation from 2009David Lee Scher, MD
This presentation discussing interoperability was given at the European Society of Cardiology in 2009.This remains an important topic for healthcare worldwide. Addendum: All names shown are fictitious and not real patients.
Unit VI Case StudyAnimal use in toxicity testing has long been .docxdickonsondorris
Unit VI: Case Study
Animal use in toxicity testing has long been a controversial issue; however, there can be benefits. Read “The Use of Animals in Research,” which is an article that can be retrieved from http://www.toxicology.org/pubs/docs/air/AIR_Final.pdf.
Evaluate the current policies outlined in the Position Statement on page 5 of the article. Use the SOT Guiding Principles in the Use of Animals in Toxicology to guide you in your analysis. Feel free to use additional information and avenues of information, including the textbook, to critically analyze this policy.
In addition, answer the following questions:
How do toxicologists determine which exposures may cause adverse health effects?
How does the information apply to what you are learning in the course?
What were the objectives of this toxicity testing?
What were the endpoints of this toxicity testing?
Finally, include whether or not you agree with the Society of Toxicology's position on animal testing.
Your Case Study assignment should be three to four pages in length. Use APA style guidelines in writing this assignment, following APA rules for formatting, quoting, paraphrasing, citing, and referencing.
Adventure Works Marketing Plan
Centralizing Medical Information To Improve Patient Care
(
Centralizing Medical Information To Improve patient Care
)
Contents
Centralizing Medical Information To Improve patient Care0
Contents1
History2
Executive Summary2
High-Level Functional Requirements:4
Project Charter4
Business Problem Statement5
Project Scope5
Budget and Schedule6
Strategy6
SWOT ANALYSIS6
Technology Constraints7
Project Documentation and Communication9
Project Organization and Staffing Approach9
Project Value Statement9
History
The Affordable Care Act law was passed to improve healthcare for its citizens in the United States by increasing the people that have health insurance and by decreasing healthcare cost. A benefactor to this law is the Medicare/Medicaid program which provides medical coverage to the poor, elderly and disabled individuals which is funded by the federal government. The Federal government covers funding for Medicare programs while it provides reimbursement funds for Medicaid programs provided by the states. (The National Federation Of Independent Business V Sebellius, Secretary Of Health And Human Services, 2012). The primary benefits of the Affordable Care Act Law are covering more consumers with improved quality of services while reducing healthcare cost, access to healthcare, and consumer protection. (ASPA, 2014) Centers For Medicare and Medicaid Services (CMS) manages both of these programs and by modernizing and strengthening the current system they will be lowering cost and providing quality care. Executive Summary
The Center for Medicare and Medicaid (CMS) is the federal office to organized the integration of Medicaid and Medicare services across multiple agencies nationwide. Its purpose is to improve access to services, ...
eHealth Practice in Europe: where do we stand?chronaki
eHealth as the use of Information and communication technologies in the practice of health care comprises Electronic health records, Healthcare information exchange cross-jurisdictions, Personal health records, Telehealth, telemedicine and remote monitoring.
There are several efforts to reflect and measure the practice of eHealth including efforts by the OECD and WHO, but in general there is little reported sharing of health data particularly with patients. Specific barriers frequently mentioned are supporting policies and coherent widely implemented standards.
The presentation discusses relevant efforts and programs supported by the European Commission such as the eHealth DSI, eStandards, ASSESS CT, and openMedicine aiming at large scale eHealth adoption It calls for engagement of European Society, its national societies, and its members.
Mobile devices are enforcing its use in all aspects of life, health care is one major area where mobile device could enhance operations, or improve quality and efficincy. Here is a presentation I gave at HIMSS which may be useful to you if you are considering using mobile device in your health care discpline.
In this full-day tutorial, you will learn basic overview of electronic medical records systems, health data management and how you can use the OpenMRS system for data and information management. We will cover basics of installation, user management, location management, patient dashboards and some interesting features that are provided by different modules. You can see how OpenMRS can be customized with different modules that are suitable for different contexts. This tutorial is helpful for new users and developers who would like to know the features of OpenMRS. Individuals who would like to evaluate and try to see if OpenMRS fits their healthcare needs will also benefit from this tutorial.
Mobile Technology in Medical InformaticJAMES JACKY
1. Mobile Technology in Medical Informatic
2. Mobile Health
3. The Cloud
4. MediHome
5. Itareps
6. Advantages of Mobile Technology in Medical Informatic
7. Problems faced in implementing mobile technology in medical healthcare
8. How does the systems work?
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Leveraging emerging standards for patient engagement pcha
1. Tom Martin (HIMSS)
John Sharp (HIMSS)
David Collins (HIMSS)
Michael J. Kirwan (PCHA-Continua)
Michael Brown (Ascend Integrated)
Barry Dickman (AEGIS.net, Inc.)
How to Leverage Emerging Standards & Guidelines
for Patient Engagement
1
2. • Business Case
– Why should we care?
• How PGHD Benefits Patient Engagement
• FDA Standards & Health Devices
• Limitations of Data Exchange
• Mobile Device & EHR Interactivity
• Conclusion
Agenda
2
3. • Patients are playing an increasingly important role in creating
relevant healthcare data about themselves using mobile devices
and applications.
– It is important this data can move with them securely throughout a
healthcare ecosystem.
• The increased use of medical devices and mobile applications opens
the dialogue around open source and non-proprietary standards
with complementing policies.
• Trust and verification of data and data sources are achieved by
implementing the proper information exchange standards from
design to implementation.
• Adopting a common framework ensures access to high-quality data
and promotes reliability across multiple platforms, enabling an
enhanced dialogue between providers and patients.
Executive Summary and Introduction
3
5. Challenges:
• Multiple Patient Portals
– Patients having multiple portals to capture/log-in to access their
records
– Maintaining difference versions of records
– No ability to move data to a single, consolidated EHR/EMR
– Does not ensure the functionality of a longitudinal health record
– Growing importance of patient access to healthcare data
• Different focus moving from healthcare to health avoidance
– Context of healthcare in our everyday lives
– Healthcare as perceived as the lack of health
– Development of a health scale
Business Case
5
6. Problem:
• Patients must have the ability to
collect and share data
–Establish baseline of their own
healthcare data points
–Ability to want to watch for changes
when healthcare becomes
necessary/more expenses
Business Case – Cont’d
6
7. • Limited patient engagement
• Transition to alternative payment models which
focus on outcomes
• Vendor community building devices that do not
follow open source standards-based technology
– As consumers, need devices that are consuming data
in an industry-based way (e.g., EHR, EMR , PHR, etc.)
– Not being collected & consumed in a clinically
relevant way for decision-makers/providers
Why Should We Care?
7
8. How PGHD Benefits Patient Engagement
Data from Devices to the EHR
High risk, high cost patients at
risk for readmission, ER visits
benefit from monitoring
Remote patient monitoring
devices pass data seamlessly to
the EHR
Algorithms identify data trends
which show potential
deterioration 8
9. How PGHD Benefits Patient Engagement
Based on data from remote patient
monitoring, medical team contacts patient
and family caregivers to adjust treatment
Ensure true coordination of care for patients
Patients can view data trends through the
patient portal
Patients communicate with their provider
team via secure messaging
9
10. Case Example Snapshot
Carolinas Healthcare – apps and
devices
• Carolinas Tracker enables
consumers in the community to
aggregate their health data from
apps and devices into one place and
view a dashboard to see where they
need to focus their attention
• Carolinas Healthcare App –
comprehensive patient portal
• Diabetes Coaching App Program 10
11. • Detailed clinical data that can be evaluated for
patterns and displayed appropriately for
providers.
• Help to determine adverse events/critical clinical
indicators
• Precision medicine links data points (clinical
events) with real-time self reporting via mobile
devices
• Use of standards-based technology could support
the multiple use and interpretation of clinical
events / real-time self reporting
Benefits
11
13. FDA Recognized Standards around Digital Health
Devices
• The FDA currently recognizes a wide variety of industry standards
related to wireless medical devices which also impact mobile medical
applications.
• The current cadre of FDA recognized standards leans toward issues
associated with wireless “cross talk” or connectivity. This focus on
connectivity issues which has a subsequent and significant impact on
the delivery or transport of information. However, the need to timely
access to information also presents a need for quality-based
standards on patient access.
• The other component of transporting information –aside from
connectivity between devices - is the need for the ability to move
information between data repositories for effective analysis across
platforms. The results in establishing a relational understanding of
data between two digital health platforms. 13
14. Impact for Connected Health and Personally
Generated Health Data
• Currently, there is limited focus among the FDA on
recognizing standards which impact the generation of
data and the capability to successfully move this
information between “data warehouses” or locations
where data is analyzed by different platforms.
• Medical grade devices must address the following:
– Location of Care: Acute vs. Ambulatory vs. Home Care, vs
Others
– Leverage existing data transport standards
14
15. ONC Meaningful Use Stage 3: Focus on APIs
• Meaningful Use Stage 3 objectives focus largely on the use
of APIs for the access of information within programs.
• From - Medicare and Medicaid Programs; Electronic Health
Record Incentive Program—Stage 3 and Modifications to
Meaningful Use in 2015 through 2017
– View their health information;
– Download their health information;
– Transmit their health information to a third party; and
– Access their health information through an API.
• Future efforts by ONC to include API certification programs
15
17. Current Limitations of Data Exchanges
• According to a survey conducted in 2014 by
Research Now, mHealth users get more out of an
EHR than traditional desktop applications.
• EHR and Mobile standards allow for both push
and pull notifications to occur between an
enterprise EHR and a mobile device.
• Many healthcare providers have developed
Application Programming Interfaces (APIs),
allowing a mobile device to push certain data sets
into an EHR.
• Accessing EHR data repositories through a single
mobile interface is an industry next step.
17
18. Current Limitations of Data Exchanges
• Platforms must enable true interoperability (push and pull
data securely) between medical and non-medical devices and
EHR systems.
– Engineers are working to transform traditionally defined healthcare
data into JSON, a consumable format for mobile devices.
– HL7 Fast Healthcare Interoperability Resources (FHIR) is a healthcare
information exchange standard that provides a method for mobile
devices to pull & push (Bi-directional information exchange) from an
enterprise EHR.
• Secure SMS messaging standards, such as HL7 mFHAST allows
EHRs to push secure text notifications to patient
– Restricted to 140 characters per message.
– One-way communication, not intended for sending large quantities of
data. 18
19. Security Standards and Recent Developments
• The National Institute of Standards and Technology (NIST)
released mobile device security guidelines for comment from
the public. The guidelines provide a framework for the
following:
– Networking Infrastructure Services
– Backup & Disaster Recovery (DR)
– Configuration Management
– Intrusion Detection Systems (IDS)
– Certificate Authorities (Secure Socket Layer (SSL))
– Identity and Access Control
– Operating Systems
19
20. International Standards for Mobile Devices
• The International Organization for Standards (ISO) and International
Electrotechnical Commission (IEC) regulates all standards
internationally for medical devices and mobile healthcare.
• They are international standards, subsequently any region or
country can adopt these standards.
• Several of the international standards around mobile & medical
devices include:
– ISO 14971:2007: Medical Devices – Application of Risk Management
to Medical Devices
– ISO 13485:2003: Medical Devices – Quality Management Systems –
Requirements for Regulatory Purposes
– IEC 62366-1:2015: Medical devices — Part 1: Application of usability
engineering to medical devices
– ISO/IEEE 11073-20601: Optimized Exchange Protocol
20
21. U.S. Standards for Medical Devices
• The U.S. uses the American National Standards Institute
(ANSI), the U.S. representative to the ISO.
• There are two organizations approved by ANSI specifically
for Medical Device standards definitions:
– Advancement of Medical Instrumentation (AAMI)
– American Society for Quality (ASQ)
• Below are examples of standards used for Medical Devices:
– ANSI/AAMI/ISO 13485:2003 (R2009): Medical devices —
Quality management systems - Requirements for regulatory
purposes
– ANSI/AAMI/ISO 14971:2007 (R2010): Medical devices —
Application of risk management to medical devices
– ANSI/ISO/ASQ Q9001-2008: Quality management systems —
Requirements (U.S. version of ISO 9001:2008) 21
22. European Union Standards
• The EU has two standards organizations, European
Committee for Standardization (CEN) and European
Committee for Electrotechnical Standardization
(CENELEC). Examples include:
– EN ISO 13485:2012: Medical devices — Quality
management systems — Requirements for regulatory
purposes
– EN ISO 14971:2012: Medical devices — Application of risk
management to medical devices
• The Medical Device Directive (MDD), Active
Implantable Medical Device Directive (AIMDD), and the
In Vitro Diagnostic Directive (IVDD) define
requirements for particular types of medical devices. 22
23. Additional Standards Considerations
• A region or country may adopt an international
standard and place certain constraints on the
standard.
– The U.S. may adopt medical device / mobile health
standards.
– Many of the standards defined at the International
(ISO) level may be modified from the original standard
to fit a specific country (much like ANSI).
• U.S. standards organizations may adopt various
standards, however regulatory authorities such as
the FDA are not required to recognize these
standards. 23
25. Standards Enabling the Effective Transportation of
Healthcare Information
• Devices
– IEEE 11073 (Currently covers 16 device specializations)
– Bluetooth (Classic basic rate and Smart covering an additional 6 device
specializations)
– Devices (Weighing Scale, Body Comp. Analyzer, Heart Rate, Blood Pressure,
Insulin Pump, Continuous Glucose Monitor,
• Services
– HTTPS / SOAP / XML
– REST / hData / JSON
– HL7 FHIR
– Also HL7 3.0 via the Personal Health Monitoring Record Also via IHE’s new
Remote Patient Monitoring Profile (which is nearly an approved IHE Profile
that will be tested within the next IHE Connectathon in January 2016).
25
27. Conclusion
• Patients need more accessibility over their
data.
– Engineers are challenged to enable secure and
reliable data transfer / exchange between existing
systems and mobile devices.
– Engaging patients via mobile devices improves
health outcomes and quality of care.
• Engaging patients will occur through the use
of mobile devices and industry standards /
best practices. 27